BRIEF-Teleflex Receives FDA 510(K) Clearance For Expanded Indications Of The QuikClot Control+™ Hemostatic Device

Reuters
30 Apr
BRIEF-Teleflex Receives FDA 510<a href="https://laohu8.com/S/K">$(K)$</a> Clearance For Expanded Indications Of The QuikClot Control+™ Hemostatic Device

April 30 (Reuters) - Teleflex Inc TFX.N:

  • TELEFLEX RECEIVES FDA 510(K) CLEARANCE FOR EXPANDED INDICATIONS OF THE QUIKCLOT CONTROL+™ HEMOSTATIC DEVICE

Source text: ID:nGNX1YprB0

Further company coverage: TFX.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10